AbbVie (ABBV) is set to report Q2 2026 earnings, with analysts estimating $16.76 billion in revenue and $3.63 EPS, and the stock is in an uptrend with positive relative strength.
Source Post
Abbvie $ABBV Q2 2026 Earnings Preview
Jul 27, 2026
This video previews AbbVie's (ABBV) Q2 2026 earnings report, scheduled for July 31st. It highlights past performance, current analyst estimates for revenue and EPS, historical estimate beat rates, technical indicators like uptrend and positive relative strength, and the options market's implied move. Short interest is also noted.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.